132 related articles for article (PubMed ID: 32768316)
21. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
22. The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery.
Rutten IJ; Ubachs J; Kruitwagen RF; van Dijk DP; Beets-Tan RG; Massuger LF; Olde Damink SW; Van Gorp T
Eur J Surg Oncol; 2017 Apr; 43(4):717-724. PubMed ID: 28159443
[TBL] [Abstract][Full Text] [Related]
23. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.
Deng HY; Zha P; Peng L; Hou L; Huang KL; Li XY
Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30496385
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
[No Abstract] [Full Text] [Related]
25. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma.
Fukushima H; Yokoyama M; Nakanishi Y; Tobisu K; Koga F
PLoS One; 2015; 10(1):e0115895. PubMed ID: 25612215
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Camus V; Lanic H; Kraut J; Modzelewski R; Clatot F; Picquenot JM; Contentin N; Lenain P; Groza L; Lemasle E; Fronville C; Cardinael N; Fontoura ML; Chamseddine A; Brehar O; Stamatoullas A; Leprêtre S; Tilly H; Jardin F
Eur J Haematol; 2014 Jul; 93(1):9-18. PubMed ID: 24520908
[TBL] [Abstract][Full Text] [Related]
27. The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer.
Benjamin AJ; Buschmann MM; Zhang SQ; Wroblewski K; Kindler HL; Roggin KK; Dale W
J Geriatr Oncol; 2018 Jul; 9(4):367-372. PubMed ID: 29534880
[TBL] [Abstract][Full Text] [Related]
28. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.
Shachar SS; Williams GR; Muss HB; Nishijima TF
Eur J Cancer; 2016 Apr; 57():58-67. PubMed ID: 26882087
[TBL] [Abstract][Full Text] [Related]
30. Adult primary testicular lymphoma: clinical features and survival in a series of patients treated at a high-volume institution in China.
Chen B; Cao DH; Lai L; Guo JB; Chen ZY; Huang Y; Qiu S; Lin TH; Gou Y; Ma N; Yang L; Liu LR; Wei Q
BMC Cancer; 2020 Mar; 20(1):220. PubMed ID: 32171265
[TBL] [Abstract][Full Text] [Related]
31. Opportunistic Measurement of Skeletal Muscle Size and Muscle Attenuation on Computed Tomography Predicts 1-Year Mortality in Medicare Patients.
Lenchik L; Lenoir KM; Tan J; Boutin RD; Callahan KE; Kritchevsky SB; Wells BJ
J Gerontol A Biol Sci Med Sci; 2019 Jun; 74(7):1063-1069. PubMed ID: 30124775
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Overall Survival and Progression-Free Survival by the
Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
[No Abstract] [Full Text] [Related]
33. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.
Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ
JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857
[TBL] [Abstract][Full Text] [Related]
34. Severe muscle loss during radical chemoradiotherapy for non-metastatic nasopharyngeal carcinoma predicts poor survival.
Huang X; Ma J; Li L; Zhu XD
Cancer Med; 2019 Nov; 8(15):6604-6613. PubMed ID: 31517443
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of 1p deletion for multiple myeloma: a meta-analysis.
Ouyang J; Gou X; Ma Y; Huang Q; Jiang T
Int J Lab Hematol; 2014 Oct; 36(5):555-65. PubMed ID: 24460694
[TBL] [Abstract][Full Text] [Related]
36. Different methods for diagnosis of sarcopenia and its association with nutritional status and survival in patients with advanced cancer in palliative care.
da Silva JR; Wiegert EVM; Oliveira L; Calixto-Lima L
Nutrition; 2019 Apr; 60():48-52. PubMed ID: 30529186
[TBL] [Abstract][Full Text] [Related]
37. The Association Between Computed Tomography-Defined Sarcopenia and Outcomes in Adult Patients Undergoing Radiotherapy of Curative Intent for Head and Neck Cancer: A Systematic Review.
Findlay M; White K; Lai M; Luo D; Bauer JD
J Acad Nutr Diet; 2020 Aug; 120(8):1330-1347.e8. PubMed ID: 32711854
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
Guo B; Tan X; Ke Q; Cen H
PLoS One; 2019; 14(1):e0210224. PubMed ID: 30625203
[TBL] [Abstract][Full Text] [Related]
39. The impact of computed tomography-assessed sarcopenia on outcomes for trauma patients - a systematic review and meta-analysis.
Xia W; Barazanchi AWH; MacFater WS; Hill AG
Injury; 2019 Sep; 50(9):1565-1576. PubMed ID: 31280971
[TBL] [Abstract][Full Text] [Related]
40. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Surov A; Pech M; Gessner D; Mikusko M; Fischer T; Alter M; Wienke A
Clin Nutr; 2021 Oct; 40(10):5298-5310. PubMed ID: 34536638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
